PA8454501A1 - Composiciones farmaceuticas que contienen eletriptan hemisulfato - Google Patents

Composiciones farmaceuticas que contienen eletriptan hemisulfato

Info

Publication number
PA8454501A1
PA8454501A1 PA19988454501A PA8454501A PA8454501A1 PA 8454501 A1 PA8454501 A1 PA 8454501A1 PA 19988454501 A PA19988454501 A PA 19988454501A PA 8454501 A PA8454501 A PA 8454501A PA 8454501 A1 PA8454501 A1 PA 8454501A1
Authority
PA
Panama
Prior art keywords
pharmaceutical compositions
compositions containing
eletriptan hemisulphate
containing eletriptan
hemisulphate
Prior art date
Application number
PA19988454501A
Other languages
English (en)
Inventor
Valerie Denise Harding
Anne Billote
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PA8454501A1 publication Critical patent/PA8454501A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA PRESENTE INVENCION PROPOCIONA UNA COMPOSICION FARMACEUTICA ACUOSA QUE COMPRENDE DE 5 A 200 MG/ML DE ELETRIPTAN HEMISULFATO Y DEL 0,5 A 2,0% EN PESO/VOLUMEN DE CAFEINA.
PA19988454501A 1997-07-03 1998-07-01 Composiciones farmaceuticas que contienen eletriptan hemisulfato PA8454501A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714081.8A GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions
GBGB9718270.3A GB9718270D0 (en) 1997-07-03 1997-08-28 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PA8454501A1 true PA8454501A1 (es) 2000-05-24

Family

ID=10815339

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19988454501A PA8454501A1 (es) 1997-07-03 1998-07-01 Composiciones farmaceuticas que contienen eletriptan hemisulfato

Country Status (13)

Country Link
KR (1) KR100384346B1 (es)
AP (1) AP1100A (es)
AR (1) AR013165A1 (es)
CO (1) CO4950555A1 (es)
GB (2) GB9714081D0 (es)
GT (1) GT199800105A (es)
HN (1) HN1998000101A (es)
MY (1) MY119643A (es)
PA (1) PA8454501A1 (es)
PE (1) PE84499A1 (es)
TN (1) TNSN98126A1 (es)
UA (1) UA49955C2 (es)
ZA (1) ZA985812B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
AR013165A1 (es) 2000-12-13
HN1998000101A (es) 1999-01-08
AP9801290A0 (en) 1998-09-30
CO4950555A1 (es) 2000-09-01
KR100384346B1 (ko) 2003-05-16
GT199800105A (es) 2000-01-04
GB9714081D0 (en) 1997-09-10
PE84499A1 (es) 1999-09-11
AP1100A (en) 2002-09-02
KR20010014366A (ko) 2001-02-26
MY119643A (en) 2005-06-30
TNSN98126A1 (fr) 2005-03-15
ZA985812B (en) 2000-01-10
GB9718270D0 (en) 1997-11-05
UA49955C2 (uk) 2002-10-15

Similar Documents

Publication Publication Date Title
ES2163291T3 (es) Composiciones farmaceuticas que contienen eletriptan hemisulfato y cafeina.
ES2190075T3 (es) Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico.
ES2194452T3 (es) Composiciones antitranspirantes que contienen 1,2-hexanodiol.
ES2093735T3 (es) Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica.
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
ES2181501T3 (es) Composicion cosmetica.
ES2184293T3 (es) Composiciones farmaceuticas administrables por via oral que comprenden una benzhidrilpiperazina y una ciclodextrina.
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
ATE310738T1 (de) Gesättigte 1,2-dithiaheterocyclische verbindungen enthaltende antivirale pharmazeutische zubereitungen
UY24308A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
ES2180573T3 (es) Uso de derivados de indol como antagonistas de 5ht1.
TR199700858A2 (xx) Alzheimer hastal���n�n tedavisine y�nelik ispen�iyari bile�imler.
PA8454501A1 (es) Composiciones farmaceuticas que contienen eletriptan hemisulfato
ECSP982578A (es) Composiciones farmaceuticas que contienen eletriptan hemisulfato
HN2000000057A (es) Derivados de i - trifluorometil-4-hidroxi-7-piperidinil- aminometilcromano.
KR970073583A (ko) 탁속을 함유한 주사용 약제 조성물
AR023056A1 (es) Composiciones farmaceuticas basadas en alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh
ES2175086T3 (es) Composiciones farmaceuticas anti-emeticas que contienen metotrimeprazina.
BR9805026A (pt) Compostos contdndo tetrahidrolipstatina
ECSP003597A (es) Derivados de pirrolidin - 2, 3, 4- trion -3- oxima sustituida procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de estos compuestos para la preparacion de medicamentos
GT199800086A (es) Formulaciones farmaceuticas que contienen voriconazol.